ReviewCureus2025
Clinical and Environmental Harms of Quaternary Ammonium Disinfectants and the Promise of Ultraviolet-C (UV-C) Alternatives: A Narrative Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A New Sustainable Approach to Antibiotic Resistance: Development of bis-Quaternary Ammonium Salts From 2,4,6-Trichloro-1,3,5-Triazine.ChemMedChem · 2026Article
- Fate of Benzalkonium Chloride in Nanofiltration and Reverse Osmosis: Mechanisms of Retention and Membrane Response.Molecules (Basel, Switzerland) · 2026Article
- Beyond Urticaria: Acute Airborne Contact Dermatitis in a Hospital Worker Presenting to the Emergency Department.Cureus · 2025Article
- Mitigation Techniques of Membranes' Biofouling in Bioelectrochemical Cells (BEC Cells): Recent Advances.Membranes · 2025Review
- Structure-Function Insights into Quinuclidine-3-One BisQACs: Synthesis, Modulation of Bacterial Resistance, Structure-Activity Relationship, and Biological Profiling.Pharmaceuticals (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quaternary ammonium compounds (QACs) are widely used disinfectants whose application expanded dramatically during the COVID-19 pandemic, raising concerns about long-term safety and environmental impact. This narrative review begins by outlining the chemical structure, mechanisms of action, and widespread use of QACs across healthcare, consumer, and industrial settings. We examine toxicologic findings from in vitro and animal studies, highlighting mitochondrial dysfunction, oxidative stress, and reproductive toxicity at low-dose exposures. Clinical and public health data are reviewed, linking QAC exposure to respiratory symptoms, dermatitis, and potential reproductive risks among healthcare workers and other vulnerable populations. Environmental harms are also discussed, including QAC persistence in soil and water, ecotoxicity in aquatic species, and potential for bioaccumulation. We then explore ultraviolet-C (UV-C) disinfection as a non-chemical alternative, demonstrating comparable antimicrobial efficacy without the toxicological or ecological drawbacks of QACs. Despite the growing use of QACs, few studies have comprehensively reviewed their adverse effects or evaluated UV-C as a viable substitute. This narrative review fills a critical gap by synthesizing current evidence across disciplines and highlighting the need for safer disinfection practices. We advocate for the broader adoption of UV-C technologies to reduce chemical exposure, protect public health, and promote environmental sustainability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.